Light-triggered nanoparticles promise cure for metastatic cancer

    Source: Xinhua| 2018-01-26 06:24:35|Editor: Mu Xuequan
    Video PlayerClose

    CHICAGO, Jan. 25 (Xinhua) -- Light emitted as part of traditional cancer-imaging techniques to locate metastatic tumors can also trigger light-sensitive drugs, according to a study of Washington University School of Medicine in St. Louis.

    Researchers at the university found that when such drugs are packaged into nanoparticles that target lit-up cancer cells, the light-sensitive drug produces toxic free radicals that kill the tumor cells, and the technique worked effectively in mice with multiple myeloma, a cancer of white blood cells, and aggressive metastatic breast cancer.

    The technology harnesses a chemotherapy drug called titanocene. As a chemotherapy agent alone, titanocene has not worked well in clinical trials, even at relatively high doses. But when exposed to the radiation emitted by visible light, titanocene produces reactive particles that are toxic to cells, even at low doses.

    Researchers at Washington University packaged low doses of titanocene inside nanoparticles they targeted to proteins known to sit on the surface of cancer cells, and found that when the nanoparticles make contact with cancer cells, their membranes fuse together, releasing the titanocene into the cells.

    They then deliver a common cancer imaging agent called fluorodeoxyglucose (FDG), a type of sugar. Energy-hungry cancer cells take up the FDG at high rates, causing tumors to glow in a positron emission tomography (PET) scan. This glow also triggers the titanocene, releasing free radicals and killing the cells.

    As the titanocene and the light-emitting FDG are targeted to the same place at the same time only in tumors, the technique is believed to be less toxic than standard radiation and chemotherapy.

    Research also shows that the body rids itself of titanocene through the liver, while FDG is cleared through the kidneys. The fact that the two components are disposed of separately minimizes damage to other organs.

    The researchers have tested the strategy on mice with multiple myeloma once a week for four weeks. In the weeks following, the treated mice had significantly smaller tumors and survived longer than the control mice. Fifty percent of treated mice survived at least 90 days, while 50 percent of control mice survived 62 days.

    The mice with breast cancer also showed an anti-tumor effect when treated using this strategy, though less pronounced than in those with multiple myeloma, likely due to the extreme aggressiveness of the breast cancer cell line, the researchers said.

    The researcher also found that certain types of multiple myeloma were resistant to this technique.

    The study has been published online in Nature Communications.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011105091369252951
    主站蜘蛛池模板: 新婚娇妻1一29芷姗txt下载| 国产曰批免费视频播放免费s| 日韩毛片无码永久免费看| 免费看**一片毛片| 黄色一级毛片免费看| 无遮挡又黄又爽又色的动态图1000 | 精品国产18久久久久久| 在线精品免费视频| 亚洲aⅴ男人的天堂在线观看| 视频一区在线免费观看| 娃娃脸1977年英国| 久久精品女人天堂AV麻| 精品人成电影在线观看| 国产特级毛片aaaaaa高清| 中文永久免费观看网站| 欧美大屁股xxxx| 国产一区二区三区电影| 99热在线获取最新地址| 无人视频在线观看免费播放影院| 亚洲午夜久久久影院伊人| 色噜噜狠狠色综合中国| 在线观看国产一区| 中文字幕在线亚洲精品| 欧美日韩国产乱了伦| 国产人妖ts在线观看网站| eeuss影影院www在线播放| 欧美丰满熟妇xx猛交| 国产一级特黄a大片免费| 菠萝视频在线完整版| 天天夜碰日日摸日日澡| 九一制片厂果冻传媒56| 精品福利一区二区三区| 国外免费直播性xxxx18| 三级在线看中文字幕完整版| 日韩欧美国产成人| 亚洲国产欧美另类| 男女同房猛烈无遮挡动态图| 国产 欧洲韩国野花视频| 高清国语自产拍免费视频| 天天操天天干天天爽| 亚拍精品一区二区三区|